Annual ROE
-107.78%
-72.32%-203.95%
December 31, 2022
Summary
- As of February 10, 2025, TCRR annual return on equity is -107.78%, with the most recent change of -72.32% (-203.95%) on December 31, 2022.
- During the last 3 years, TCRR annual ROE has fallen by -78.11% (-263.26%).
Performance
TCRR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-97.81%
-23.84%-32.23%
March 31, 2023
Summary
- As of February 10, 2025, TCRR quarterly return on equity is -97.81%, with the most recent change of -23.84% (-32.23%) on March 31, 2023.
- Over the past year, TCRR quarterly ROE has dropped by -61.15% (-166.80%).
Performance
TCRR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TCRR ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -203.9% | -166.8% |
| 3 y3 years | -263.3% | -203.8% |
| 5 y5 years | -317.1% | -422.0% |
TCRR ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +203.9% | at low | +210.3% | at low |
| 5 y | 5-year | +279.8% | at low | +262.8% | at low |
| alltime | all time | -229.2% | at low | -281.5% | +10.8% |
TCR2 Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -97.81%(+32.2%) |
| Dec 2022 | -107.78%(+203.9%) | -73.97%(+49.4%) |
| Sep 2022 | - | -49.52%(+15.4%) |
| Jun 2022 | - | -42.91%(+17.0%) |
| Mar 2022 | - | -36.66%(+16.3%) |
| Dec 2021 | -35.46%(+24.9%) | -31.52%(+6.3%) |
| Sep 2021 | - | -29.64%(+6.5%) |
| Jun 2021 | - | -27.82%(-7.5%) |
| Mar 2021 | - | -30.09%(-13.8%) |
| Dec 2020 | -28.38% | -34.92%(-1.7%) |
| Sep 2020 | - | -35.51%(-7.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -38.18%(+18.6%) |
| Mar 2020 | - | -32.20%(+19.4%) |
| Dec 2019 | -29.67%(-204.8%) | -26.96%(-27.0%) |
| Sep 2019 | - | -36.91%(+10.4%) |
| Jun 2019 | - | -33.42%(-12.6%) |
| Mar 2019 | - | -38.22%(-64.7%) |
| Dec 2018 | 28.30%(-43.0%) | -108.34%(+174.2%) |
| Sep 2018 | - | -39.51%(-173.3%) |
| Jun 2018 | - | 53.89%(+77.4%) |
| Mar 2018 | - | 30.38%(+99.3%) |
| Dec 2017 | 49.65%(-40.5%) | 15.24% |
| Dec 2016 | 83.43% | - |
FAQ
- What is TCR2 Therapeutics annual return on equity?
- What is the all time high annual ROE for TCR2 Therapeutics?
- What is TCR2 Therapeutics annual ROE year-on-year change?
- What is TCR2 Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for TCR2 Therapeutics?
- What is TCR2 Therapeutics quarterly ROE year-on-year change?
What is TCR2 Therapeutics annual return on equity?
The current annual ROE of TCRR is -107.78%
What is the all time high annual ROE for TCR2 Therapeutics?
TCR2 Therapeutics all-time high annual return on equity is 83.43%
What is TCR2 Therapeutics annual ROE year-on-year change?
Over the past year, TCRR annual return on equity has changed by -72.32% (-203.95%)
What is TCR2 Therapeutics quarterly return on equity?
The current quarterly ROE of TCRR is -97.81%
What is the all time high quarterly ROE for TCR2 Therapeutics?
TCR2 Therapeutics all-time high quarterly return on equity is 53.89%
What is TCR2 Therapeutics quarterly ROE year-on-year change?
Over the past year, TCRR quarterly return on equity has changed by -61.15% (-166.80%)